Undercurrent CapitalbetaSign in

Science Raises $400 Million for Sight-Restoring Implant

TLDR — The financing backs PRIMA’s European rollout and a planned US launch that still requires FDA approval....

Signal data▲ Bullishconfidence 50%Low materiality
AssetEventsector-trendEvent timeAttention0 readers/hrNormalSmart readers0

The financing backs PRIMA’s European rollout and a planned US launch that still requires FDA approval.... Read the full story at The Defiant

0 impressions · 0 upvotes · 0 comments

Reading is open to everyone — posting, replying and reporting need an account.

No comments yet.